BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2022
View Archived Issues
Targeting NQO1 shows protective effects in models of diabetic nephropathy
Read More
Researchers present novel capsule-mediated gastrointestinal mRNA delivery approach
Read More
Preclinical data presented for ch128.1/IgG1 in NWM hemorrhagic fever
Read More
IDP Discovery Pharma presents data on IDP-410 in preclinical glioblastoma
Read More
Antibody DH-1047 shows protection against SARS-related strains and SARS-CoV-2 variants
Read More
Heterozygous variants in the CD36 gene linked to bleeding phenotypes
Read More
Roche patents new TLR antagonists for autoimmune disease
Read More
Researchers divulge SSTR4 agonists for treatment of pain
Read More
Beijing Tide Pharmaceutical synthesizes new ATR kinase inhibitors
Read More
Chiesi Farmaceutici identifies new TGFBR1 inhibitors for IPF
Read More
Wuhan LL Science and Technology Development presents new ROCK inhibitors
Read More
In vitro data show proof of concept for Theralase SARS-CoV-2 vaccine
Read More
Navidea sponsors research at Penn to evaluate Tc99m tilmanocept as prognostic marker in glioblastoma
Read More
Novel PSCA CAR_s15 NK cell immunotherapy prolongs survival in pancreatic cancer model
Read More
Researchers publish data on VIP-236 as a promising antitumoral agent
Read More
Three components enable 3D kidney tissue from mouse embryonic stem cells
Read More